Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line

British Journal of Cancer

Volumn 84, Issue 11, 2001, Pages 1528-1534

  Appierto, V ^a   Cavadini, E ^a   Pergolizzi, R ^a   Cleris, L ^a   Lotan, R ^b   Canevari, S ^a   Formelli, F ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Differentiation; Drug uptake; Fenretinide resistance; Ovarian tumour; RAR ; Retinoids

Indexed keywords

FENRETINIDE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROTECTION; COLONY FORMING UNIT; CROSS RESISTANCE; DRUG ACCUMULATION; DRUG EFFECT; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OVARY TUMOR; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA; CELL DIFFERENTIATION; DRUG RESISTANCE, NEOPLASM; FEMALE; FENRETINIDE; HUMANS; OVARIAN NEOPLASMS; RECEPTORS, RETINOIC ACID; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035365180     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1826     Document Type: Article

References (19)

1. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer
2. Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines
3. Retinoid receptor-dependent and - Independent effects of N-(4-hydroxyphenyl) retinamide in F9 embryonal carcinoma cells
4. Can fenretinide protect women against ovarian cancer?
5. Ultrastructural and phenotypic characterization of CABA I, a new human ovarian carcinoma cell line
6. 4-hydroxyphenyl retinamide is a highly selective activator of retinoid receptors
7. Five year administration of fenretinide: Pharmacokinetics and effects on plasma retinol concentrations
8. Bioactivities of N-(4-hydroxyphenyl)retinamide and retinoyl β-glucuronide
9. Tumour-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells
10. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
11. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl)retinamide
12. Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells
13. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
14. Induction of apoptosis in human neuroblastoma cells by abrogation of integrin-mediated cell adhesion
15. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression
16. UKCCCR guidelines for the welfare of animals in experimental neoplasia
17. Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody MLuC5
18. Autoinduction of retinoic acid metabolism to polar derivatives with decreased biological activity in retinoic acid-sensitive, but not in retinoic acid-resistant human breast cancer cells
19. A randomized trial of fenretinide, a vitamin A analog, to prevent second breast malignancy in women with early breast cancer